BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Sreeharsha N, Sharma S, Mishra A, Singh AK, Gubbiyappa SK. Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis. ACS Omega 2020;5:5334-9. [DOI: 10.1021/acsomega.9b04357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Muzio G, Barrera G, Pizzimenti S. Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer. Antioxidants (Basel) 2021;10:1734. [PMID: 34829605 DOI: 10.3390/antiox10111734] [Reference Citation Analysis]
2 Hooshmand S, Mahdinezhad MR, Taraz Jamshidi S, Soukhtanloo M, Mirzavi F, Iranshahi M, Hasanpour M, Ghorbani A. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytother Res 2021;35:3365-76. [PMID: 33624311 DOI: 10.1002/ptr.7056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tanaka T, Okuyama-Dobashi K, Motohashi R, Yokoe H, Takahashi K, Wiriyasermkul P, Kasai H, Yamashita A, Maekawa S, Enomoto N, Ryo A, Nagamori S, Tsubuki M, Moriishi K. Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry. Antiviral Res 2021;194:105165. [PMID: 34419484 DOI: 10.1016/j.antiviral.2021.105165] [Reference Citation Analysis]
4 Chi T, Wang M, Wang X, Yang K, Xie F, Liao Z, Wei P. PPAR-γ Modulators as Current and Potential Cancer Treatments. Front Oncol 2021;11:737776. [PMID: 34631571 DOI: 10.3389/fonc.2021.737776] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pan Y, Li J, Lou S, Chen W, Lin Y, Shen N, Li Y. Down-Regulated miR-130a/b Attenuates Rhabdomyosarcoma Proliferation via PPARG. Front Mol Biosci 2022;8:766887. [DOI: 10.3389/fmolb.2021.766887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]